Clinical Trials Browser

Phase EARLY_PHASE1 × Immune Checkpoint Inhibitors × Other solid neoplasm × Clear all

NCT05916248 2025-04-01

Combination Therapy of Personalized mRNA-0217 Vaccines and Pembrolizumab in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor